DE19975051I2 - 5,11-Dihydro-6H-dipyrido(3,2-b:2'3'-e)(1,4)diazepine und ihre Verwendung zur Verhinderung oder Behandlung von HIV-Infektionen. - Google Patents

5,11-Dihydro-6H-dipyrido(3,2-b:2'3'-e)(1,4)diazepine und ihre Verwendung zur Verhinderung oder Behandlung von HIV-Infektionen.

Info

Publication number
DE19975051I2
DE19975051I2 DE1999175051 DE19975051C DE19975051I2 DE 19975051 I2 DE19975051 I2 DE 19975051I2 DE 1999175051 DE1999175051 DE 1999175051 DE 19975051 C DE19975051 C DE 19975051C DE 19975051 I2 DE19975051 I2 DE 19975051I2
Authority
DE
Germany
Prior art keywords
dipyrido
diazepines
dihydro
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE1999175051
Other languages
English (en)
Inventor
Karl Hargrave
Guenther Dr Schmidt
Wolfhard Dr Engel
Trimmlitz Guenther Warthaus
Wolfgang Dr Eberlein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27412005&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE19975051(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Application granted granted Critical
Publication of DE19975051I2 publication Critical patent/DE19975051I2/de
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE1999175051 1989-11-17 1990-11-16 5,11-Dihydro-6H-dipyrido(3,2-b:2'3'-e)(1,4)diazepine und ihre Verwendung zur Verhinderung oder Behandlung von HIV-Infektionen. Active DE19975051I2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43892389A 1989-11-17 1989-11-17
US57900190A 1990-09-06 1990-09-06
US60039090A 1990-10-19 1990-10-19

Publications (1)

Publication Number Publication Date
DE19975051I2 true DE19975051I2 (de) 2004-05-06

Family

ID=27412005

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69033003T Expired - Lifetime DE69033003T2 (de) 1989-11-17 1990-11-16 5,11-Dihydro-6H-dipyrido(3,2-b:2'3'-e)(1,4)diazepine und ihre Verwendung zur Verhinderung oder Behandlung von HIV-Infektionen
DE1999175051 Active DE19975051I2 (de) 1989-11-17 1990-11-16 5,11-Dihydro-6H-dipyrido(3,2-b:2'3'-e)(1,4)diazepine und ihre Verwendung zur Verhinderung oder Behandlung von HIV-Infektionen.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69033003T Expired - Lifetime DE69033003T2 (de) 1989-11-17 1990-11-16 5,11-Dihydro-6H-dipyrido(3,2-b:2'3'-e)(1,4)diazepine und ihre Verwendung zur Verhinderung oder Behandlung von HIV-Infektionen

Country Status (21)

Country Link
EP (1) EP0429987B1 (de)
AP (1) AP179A (de)
AT (1) ATE177744T1 (de)
AU (1) AU630251B2 (de)
CA (1) CA2030056C (de)
DE (2) DE69033003T2 (de)
DK (1) DK0429987T3 (de)
ES (1) ES2130114T3 (de)
FI (1) FI94529C (de)
GR (1) GR3030100T3 (de)
HK (1) HK1011025A1 (de)
IE (1) IE904141A1 (de)
IL (1) IL96367A (de)
LU (1) LU90393I2 (de)
NL (1) NL990022I2 (de)
NO (2) NO175478C (de)
NZ (1) NZ236105A (de)
OA (1) OA09852A (de)
PT (1) PT95919B (de)
RU (1) RU2040527C1 (de)
UA (1) UA34420C2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
GB9109557D0 (en) * 1991-05-02 1991-06-26 Wellcome Found Chemical compounds
ATE145397T1 (de) * 1991-06-11 1996-12-15 Boehringer Ingelheim Pharma Verfahren zur herstellung von 3-amino-2-chloro-4- alkylpyridinen
US5200522A (en) * 1991-06-11 1993-04-06 Boehringer Ingelheim Pharmaceuticals, Inc. Method for preparing 3-amino-2-chloro-4-alkylpyridines
DE4138853A1 (de) * 1991-11-27 1993-06-03 Bayer Ag 5,6-dihydro-dibenz(b,e)azepin-6,11-dion-11- oxime
DE4138908A1 (de) * 1991-11-27 1993-06-03 Bayer Ag 6-thiono-dibenz(b,e)azepine
DK0598396T3 (da) * 1992-11-18 1998-11-23 Boehringer Ingelheim Pharma Forbedret fremgangsmåde til fremstilling af 3-amino-2-chlor-4-alkylpyridiner
WO1994017075A1 (en) * 1993-01-20 1994-08-04 A. Menarini Industrie Farmaceutiche Riunite S.R.L. Diazepin derivatives and antiviral compositions
DE4333697A1 (de) * 1993-10-02 1995-04-06 Merck Patent Gmbh Verfahren zur Herstellung von 3-Aminopyridinen aus 3-Nitropyridinen
DE4403311C1 (de) * 1994-02-03 1995-04-20 Boehringer Ingelheim Kg Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on)
DE69502587T2 (de) * 1994-02-18 1998-11-26 Boehringer Ingelheim Pharma 2-heteroaryl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e] [1,4]diazepine und ihre verwendung zur vorbeugung und behandlung von hiv-infektion
US5917033A (en) * 1995-10-31 1999-06-29 University Of Medicine & Dentistry Of New Jersey Structure based design of inhibitors of HIV-1 reverse transcriptase
US5747488A (en) * 1996-01-30 1998-05-05 Boehringer Ingelheim Pharmaceuticals, Inc. 2-aryl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-E! 1, 4!diazepines and their use in the treatment of HIV infection
CZ290667B6 (cs) * 1997-08-25 2002-09-11 Boehringer Ingelheim Pharmaceuticals, Inc. Farmaceutický prostředek
DE10023492A1 (de) * 2000-05-09 2001-11-22 Schering Ag Aza- und Polyazanthranylamide und deren Verwendung als Arzneimittel
US7105682B2 (en) 2001-01-12 2006-09-12 Amgen Inc. Substituted amine derivatives and methods of use
US7102009B2 (en) 2001-01-12 2006-09-05 Amgen Inc. Substituted amine derivatives and methods of use
US6878714B2 (en) 2001-01-12 2005-04-12 Amgen Inc. Substituted alkylamine derivatives and methods of use
US6995162B2 (en) 2001-01-12 2006-02-07 Amgen Inc. Substituted alkylamine derivatives and methods of use
US7307088B2 (en) 2002-07-09 2007-12-11 Amgen Inc. Substituted anthranilic amide derivatives and methods of use
US8466144B2 (en) 2004-07-16 2013-06-18 Proteosys Ag Muscarinic antagonists with parp and sir modulating activity as cytoprotective agents
US8247556B2 (en) 2005-10-21 2012-08-21 Amgen Inc. Method for preparing 6-substituted-7-aza-indoles
EP2155169B1 (de) 2007-06-08 2016-03-23 Boehringer Ingelheim International GmbH Nevirapinformulierung mit verlängerter freisetzung
EP2387405A2 (de) 2009-01-13 2011-11-23 ProteoSys AG Pirenzepin als mittel für die krebstherapie
CN107428747A (zh) 2014-11-25 2017-12-01 拜耳制药股份公司 取代的吡啶并苯并二氮杂*酮衍生物及其用途
EP3153157A1 (de) 2015-10-09 2017-04-12 Teva Pharmaceutical Works Private Limited Company Pharmazeutische zusammensetzung zur verzögerten freisetzung von nevirapin
CN107382848A (zh) * 2017-07-15 2017-11-24 河北蓝泰化工科技有限公司 一种烟酰胺化合物及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA554134A (en) * 1958-03-11 Hoffmann Karl Thia-aza-cycloheptadiene compounds and process for their manufacture
CA783570A (en) * 1968-04-23 Schmidt Gunther 5,6-dihydro-6-oxo-11h-pyrido (2,3-b) (1,4)-benzodiazepines
CA658624A (en) * 1963-02-26 Schmutz Jean Diazepine derivatives
DE3643666A1 (de) * 1986-12-20 1988-06-30 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3726908A1 (de) * 1987-08-13 1989-02-23 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3735895A1 (de) * 1987-10-23 1989-05-03 Thomae Gmbh Dr K Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0393604B1 (de) * 1989-04-20 1997-12-29 Boehringer Ingelheim Pharmaceuticals Inc. 6,11-Dihydro-5H-pyrido(2,3-b)(1,5)benzodiazepin-5-one und Thione und ihre Verwendung für die Vorbeugung oder Behandlung von AIDS
EP0393529B1 (de) * 1989-04-20 1993-06-30 Boehringer Ingelheim Pharmaceuticals Inc. 5,11-Dihydro-6H-dipyrido [3,2-b:2',3'-e]diazepin-6-one und deren Verwendung in der Vorbeugung und Behandlung von AIDS
ATE103918T1 (de) * 1989-06-28 1994-04-15 Boehringer Ingelheim Pharma 5,11-dihydro-6h-dipyrido(3,2-b:2',3'e>(1,4>diazepin-6-one und -thione und ihre verwendung bei der aids-vorbeugung oder behandlung.

Also Published As

Publication number Publication date
NL990022I1 (nl) 1999-10-01
NZ236105A (en) 1994-04-27
DE69033003T2 (de) 1999-09-16
AU6673290A (en) 1991-05-23
DE69033003D1 (de) 1999-04-22
CA2030056C (en) 1995-10-17
PT95919B (pt) 1998-01-30
OA09852A (en) 1994-08-15
EP0429987B1 (de) 1999-03-17
NO175478B (no) 1994-07-11
FI905674A0 (fi) 1990-11-16
EP0429987A2 (de) 1991-06-05
HK1011025A1 (en) 1999-07-02
CA2030056A1 (en) 1991-05-18
IE904141A1 (en) 1991-05-22
FI94529C (fi) 1995-09-25
LU90393I2 (fr) 1999-06-30
EP0429987A3 (en) 1992-01-22
NO904986L (no) 1991-05-21
AP9000224A0 (en) 1991-01-31
DK0429987T3 (da) 1999-10-11
NO175478C (no) 1994-10-19
NL990022I2 (nl) 2007-11-01
GR3030100T3 (en) 1999-07-30
IL96367A (en) 1997-02-18
ES2130114T3 (es) 1999-07-01
RU2040527C1 (ru) 1995-07-25
NO904986D0 (no) 1990-11-16
AU630251B2 (en) 1992-10-22
UA34420C2 (uk) 2001-03-15
FI905674A (fi) 1991-05-18
NO1999013I1 (no) 1999-06-29
ATE177744T1 (de) 1999-04-15
PT95919A (pt) 1991-09-13
AP179A (en) 1992-04-30
FI94529B (fi) 1995-06-15

Similar Documents

Publication Publication Date Title
DE19975051I2 (de) 5,11-Dihydro-6H-dipyrido(3,2-b:2'3'-e)(1,4)diazepine und ihre Verwendung zur Verhinderung oder Behandlung von HIV-Infektionen.
DE69130437D1 (de) Gerät mit neuronalen Netzwerken zur Detektion und Behandlung von Arrythmien
ATE235495T1 (de) 8-arylalkyl- und 8-arylheteroalkyl-5, 11-dihydro- 6h-dipyrido-(3,2-b:2', 3'-e)(1,4)diazepine und ihre verwendung zur vorbeugung oder behandlung von hiv-infektion
ATE81978T1 (de) Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen.
ATE103918T1 (de) 5,11-dihydro-6h-dipyrido(3,2-b:2',3'e>(1,4>diazepin-6-one und -thione und ihre verwendung bei der aids-vorbeugung oder behandlung.
NO892505D0 (no) Behandling av vandige dispersjoner.
DE68907569T2 (de) Mittel zur Behandlung oder Vorbeugung von Aids.
DE69412178D1 (de) Apparat zur Behandlung von Lagen
ATE116320T1 (de) 5,11-dihydro-6h-pyrido(2,3-b)(1,4)benzodiazepin 6-one und -thione und deren verwendung bei der vorbeugung und und behandlung von aids.
DE59300883D1 (de) Verfahren zur Herstellung von Dianthrachinon-N,N'-dihydroazin und dessen Chlorierungsprodukten.
ES2018613B3 (es) Procedimiento y dispositivo para la depuracion de aguas contaminadas.
ATE136463T1 (de) Verwendung von 1,2,3,4-tetrahydroacridinen zur behandlung von aids, sowie verbindungen
EP0369810A3 (de) PAF-Antagonisten als Antihyperendothelinemie-Mittel
ZA909246B (en) 5,11-dihydro-6h-dipyrido(3,2-b:2',3'-e)(1,4)diazepines and their use in the prevention or treatment of hiv infection
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
ZA951318B (en) 2-heteroaryl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4] diazepines and their use in the prevention or treatment of HIV infection
OA09307A (en) "Pyrido /2, 3-b/ /1, 5/ benzoxazepin (and thiazepin) -5(6H) -ones and-thiones and their use in the prevention or treatment of HIV infection".
ATE79759T1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
DE58902466D1 (de) Acyl-carnitin zur behandlung und zur verhuetung von virusinfektionen.
DE69822628D1 (de) Zur vorbeugung oder behandlung von östrogenabhängigen krankheiten nützliche pyrrolo[2.1.5-cd]indolizin-derivate
CA2187146A1 (en) 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e]-[1,4]- diazepines and their use in the prevention or treatment of hiv infection
DE68906028T2 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.